Boston Scientific & Symetis

We are pleased to inform you that Boston Scientific has completed its acquisition of Symetis. As part of this, you may be redirected to the Boston Scientific website on which you will find complete information on the Boston Scientific TAVI Portfolio. We are excited about adding the ACURATE™ Aortic Valve System family of products to our offering and look forward to advancing TAVI by providing the technologies needed to thoughtfully tailor treatment to each patient.

26.09.2013

Next events

Clinical results

The success of Symetis is due to our strong and continuing investment in R&D and feedback from physicians, during every step of the development process. This philosophy has enabled us to design and manufacture products that truly reflect the requirements of our clinical partners.